Lindsay Michelle Alpy, RN | |
401 New Karner Rd, Albany, NY 12205-3854 | |
(518) 334-6526 | |
Not Available |
Full Name | Lindsay Michelle Alpy |
---|---|
Gender | Female |
Speciality | Registered Nurse |
Location | 401 New Karner Rd, Albany, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184390478 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 751853 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lindsay Michelle Alpy, RN 401 New Karner Rd, Albany, NY 12205-3854 Ph: (518) 334-6526 | Lindsay Michelle Alpy, RN 401 New Karner Rd, Albany, NY 12205-3854 Ph: (518) 334-6526 |
News Archive
Researchers at Moffitt Cancer Center have found that a deficiency in an important anti-tumor protein, p53, can slow or delay DNA repair after radiation treatment. They suggest that this is because p53 regulates the expression of two enzymes (JMJD2b and SUV39H1) that control the folding of DNA.
Thursday night's vice-presidential debate was one of the best and meatiest political conversations in many years, showing that real differences on public policy can be discussed with fervor, anger, laughter and real substance. In contrast to the dismal meeting last week between President Obama and Mitt Romney, this debate gave voters a chance to evaluate the positions of the two tickets, in part because Representative Paul Ryan's nonanswers were accurate reflections of his campaign.
Individual cancer cells that break away from the original tumor and circulate through the blood stream are considered responsible for the development of metastases. These dreaded secondary tumors are the main cause of cancer-related deaths.
AstraZeneca and Rigel Pharmaceuticals Inc. today announced an exclusive worldwide license agreement for the global development and commercialization of R256, Rigel's inhaled JAK inhibitor shown to inhibit IL-13 and IL-4 signalling, which is being investigated as a treatment for moderate to severe chronic asthma. In preclinical research, R256 has been shown to reduce airway inflammation and improve lung function.
Researchers from The University of Texas Medical Branch at Galveston have found that while the 30-day readmission rate for patients with chronic obstructive pulmonary disease has decreased, the mortality rate has increased.
› Verified 7 days ago
Deborah Gelbman, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 12 Metro Park Rd, Suite 102, Albany, NY 12205 Phone: 518-437-0152 | |
Mrs. Barbara Irene Gaffuri, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 43 Bertha St, Albany, NY 12209 Phone: 518-475-6755 Fax: 518-475-6754 | |
Ms. Kelly N Miles, MS, RNC, NNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 43 New Scotland Ave, Albany, NY 12208 Phone: 518-262-9200 | |
Serena Gray, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 43 New Scotland Ave, Albany, NY 12208 Phone: 518-262-4000 | |
Marc Sopper, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 60 Academy Rd, Albany, NY 12208 Phone: 518-380-4766 Fax: 518-982-2972 | |
Kathryn Davis, RN, MS, CDE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1365 Washington Ave, Suite 300, Albany, NY 12206 Phone: 518-489-4704 Fax: 518-489-0512 | |
Mrs. Nicole Margaret Fiacco, BSN; RN, MS, PMHNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 920 Lark Dr, Albany, NY 12207 Phone: 518-465-4771 |